A291650 logo

Aptamer Sciences Inc Stock Price

KOSDAQ:A291650 Community·₩31.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A291650 Share Price Performance

₩788.00
-598.00 (-43.15%)
₩788.00
-598.00 (-43.15%)
Price ₩788.00

A291650 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

Aptamer Sciences Inc Key Details

₩0

Revenue

₩0

Cost of Revenue

₩0

Gross Profit

₩0

Other Expenses

₩0

Earnings

Last Reported Earnings
n/a
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About A291650

Founded
2011
Employees
n/a
CEO
Dongil Han
WebsiteView website
www.aptsci.com

Aptamer Sciences Inc, a bio venture company, focuses on the Aptamer technology platform for the development of therapeutic and diagnostic platforms. The company’s platforms include aptamer discovery, optimization, and the development of therapeutics and diagnostics for cancer and neurological disorders. It offers AlloMAp and Bi-Functional Aptame (BiFAp) platform programs for therapeutics, as well as Aptodetect-lung, an early diagnosis kit for lung cancer. Aptamer Sciences Inc was founded in 2011 and is headquartered in Seongnam-si, South Korea.

Recent A291650 News & Updates

Recent updates

No updates